IAPRD World Congress

CHICAGO — Preference for using a movement-prompting rehabilitation device was higher among adults with mild Parkinson’s disease, with safety concerns growing in those with more advanced disease, according to research.

CHICAGO — Adults with tardive dyskinesia prescribed deutetrabenazine had better adherence and were less likely to discontinue treatment compared with those on valbenazine, although the differences were not statistically significant.

CHICAGO — Use of an in-home therapy desk improved motor skills and balance and reduced sedentarism in adults with Parkinson’s disease, according to data at the International Association of Parkinsonism and Related Disorders World Congress.

CHICAGO — Deep brain stimulation was a cost-effective and clinically efficacious option for advanced Parkinson’s disease compared with medical therapy for patients in the Vietnamese health care system, according to research.

CHICAGO — While there is significant interest in the Black community to learn about Parkinson’s disease research and study participation, interventions are needed to reduce recruitment barriers and improve access to information.

CHICAGO — Active electrode placement in the right subthalamic nucleus in deep brain stimulation was associated with weight gain in patients with Parkinson’s disease, with lesser gain reported with medially placed electrodes.

CHICAGO — Quetiapine remains the drug of choice for psychosis in patients with Parkinson’s disease dementia and dementia with Lewy bodies, per data at the International Association of Parkinsonism and Related Disorders World Congress.

CHICAGO — Patients with tardive dyskinesia reported greater impact on quality of life than health care providers, according to a poster at the International Association of Parkinsonism and Related Disorders World Congress.

CHICAGO — Tributyrin supplementation may have a beneficial effect on motor symptoms and inflammatory markers in Parkinson’s disease, according to data at the International Association of Parkinsonism and Related Disorders World Congress.

CHICAGO — Continuous subcutaneous apomorphine infusion reduced “off” time and increased “on” time without troublesome dyskinesia in patients with Parkinson’s disease in the United States, with no new safety signals reported.